JUZINA 100 mg Romania - rumensk - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

juzina 100 mg

gedeon richter romania s.a. - romania - sitagliptinum - compr. film. - 100mg - analogi ai glp-1 inhibitori ai dipeptidil peptidazei 4 (dpp-4)

SIMLERID 100 mg Romania - rumensk - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

simlerid 100 mg

lek pharmaceuticals d.d. - slovenia - sitagliptinum - compr. film. - 100mg - analogi ai glp-1 inhibitori ai dipeptidil peptidazei 4 (dpp-4)

Januvia 100 mg comprimate filmate Moldova - rumensk - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

januvia 100 mg comprimate filmate

merck sharp & dohme idea gmbh - sitagliptinum - comprimate filmate - 100 mg

SITAGLIPTIN DR. REDDY'S 100 mg Romania - rumensk - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

sitagliptin dr. reddy's 100 mg

betapharm arzneimittel gmbh - germania - sitagliptinum - compr. film. - 100mg - analogi ai glp-1 inhibitori ai dipeptidil peptidazei 4 (dpp-4)

Sitagliptin SUN Den europeiske union - rumensk - EMA (European Medicines Agency)

sitagliptin sun

sun pharmaceutical industries europe b.v. - sitagliptin fumarate - diabetul zaharat, tip 2 - medicamente utilizate în diabet - for adult patients with type 2 diabetes mellitus, sitagliptin sun is indicated to improve glycaemic control:as monotherapy:- in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance. as dual oral therapy in combination with:- metformin when diet and exercise plus metformin alone do not provide adequate glycaemic control. - a sulphonylurea when diet and exercise plus maximal tolerated dose of a sulphonylurea alone do not provide adequate glycaemic control and when metformin is inappropriate due to contraindications or intolerance. - a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. a thiazolidinedione) when use of a pparγ agonist is appropriate and when diet and exercise plus the pparγ agonist alone do not provide adequate glycaemic control. as triple oral therapy in combination with:- a sulphonylurea and metformin when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. - a pparγ agonist and metformin when use of a pparγ agonist is appropriate and when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. sitagliptin sun is also indicated as add-on to insulin (with or without metformin) when diet and exercise plus stable dose of insulin do not provide adequate glycaemic control.

JAGLIX 100 mg Romania - rumensk - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

jaglix 100 mg

mcdermott laboratories ltd trading as gerard lab. - irlanda - sitagliptinum - compr. film. - 100mg - analogi ai glp-1 inhibitori ai dipeptidil peptidazei 4 (dpp-4)

JANSITIN 100 mg Romania - rumensk - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

jansitin 100 mg

laboratorios liconsa s.a. - spania - sitagliptinum - compr. film. - 100mg - analogi ai glp-1 inhibitori ai dipeptidil peptidazei 4 (dpp-4)

JANSITIN 25 mg Romania - rumensk - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

jansitin 25 mg

laboratorios liconsa s.a. - spania - sitagliptinum - compr. film. - 25mg - analogi ai glp-1 inhibitori ai dipeptidil peptidazei 4 (dpp-4)

JANSITIN 50 mg Romania - rumensk - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

jansitin 50 mg

laboratorios liconsa s.a. - spania - sitagliptinum - compr. film. - 50mg - analogi ai glp-1 inhibitori ai dipeptidil peptidazei 4 (dpp-4)

JAZETA 100 mg Romania - rumensk - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

jazeta 100 mg

laboratorios liconsa s.a. - spania - sitagliptinum - compr. film. - 100mg - analogi ai glp-1 inhibitori ai dipeptidil peptidazei 4 (dpp-4)